Archive

2008

• Rottapharm Biotech founded after the acquisition of the research laboratory of Basovizza, a branch of Lay Line Genomics S.p.A..
  November, 2008
  
• Rottapharm|Madaus, technical sponsor of the arctic expedition "OLTRE"
  November, 2008
  
• Epistem and Rottapharm |Madaus announce positive results
  September, 2008
  
• Depomed’s Proquin® XR, licensed for Europe to Rottapharm | Madaus, approved in Sweden
  July, 2008
  
• Rottapharm|Madaus licenses canadian rights for SANCTURA XR™ to Allergan Inc.
  May, 2008
  

2007

• June, 2007
  Rottapharm:bought 100% of Madaus Pharma, German global pharmaceutical company
  
• May, 2007
  Rottapharm announces favourable results of a pivotal phase III trial of dexloxiglumide in irritable bowel syndrome (IBS)
  
  
  

2006

• March, 2006
  GUIDE Study presented at the ECCEO6
  
  
  

2005

• July, 2005
  Rottapharm acquires Biochimici PSN
  
• May, 2005
  Sponsorship of the installation "The Writer" by Giancarlo Neri
  
• February, 2005
  Babygella/Rottapharm wins the Federculture Award*
  
• January, 2005
  Rottapharm and Xytis enter into global licensing agreement for neboglamine
  
• January, 2005
  Il fazzoletto arancione
  
  
  

2004

• November, 2004
  Arthritis: the Italian way
  
• October, 2004
  Rottapharm supports the project "Babygella – Insieme alla Scoperta dell’Arte"*
  
• February, 2004
  HRT at the ISGE Congress 2004
  
  
  

2002

• October, 2001
  NAMS 2001: New Investigator Award 2001
  
• June, 2001
  EULAR Congress 2001
  
• January, 2001
  The Lancet
  
  
  

2000

• November, 2000
  ACR 2000: Clinical study confirms previous results of Glucosamine Sulfate on joint health
  
• July, 2000
  Forest Labs announces agreement with Rotta Research for licence Dexloxiglumide
  
• December, 1999
  Rottapharm buys Guieu Labs
  
• October, 1999
  Glucosamine Sulfate reduces progression of knee osteoarthritis